QCG
CRNX icon

Quadrant Capital Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quadrant Capital Group’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-267
Closed -$13.7K – 2758
2024
Q4 		$13.7K Hold
267
– – ﹤0.01% 2030
2024
Q3 		$13.6K Hold
267
– – ﹤0.01% 2044
2024
Q2 		$12K Hold
267
– – ﹤0.01% 2056
2024
Q1 		$12.5K Buy
+267
New +$12.5K ﹤0.01% 2023